[Analysis of the clinical effectiveness of vitrum vision in the tired eye syndrome and senile macular degeneration].
The paper evaluates the clinical effectiveness of Vitrum Vision ("Unifarm") that contains a complex of carotenoids, vitamins, and trace elements, which is adapted to ocular tissue metabolic features, in the tired eye syndrome and senile macular degeneration. The use of Vitrum Vision in patients with the tired eye syndrome improved the basic parameters of photosensitivity and increased the reserve of relative accommodation and in those with myopia enhanced uncorrectable visual acuity, ameliorated the magnitude of subjective visual and ocular symptoms, and increased the duration of a visual load until sensations of eye tiredness appeared. The administration of the drug in all clinical forms of senile macular degeneration increased visual acuity, improved the basic parameters of photosensitivity, enhanced the functional activity of neurons in the central portions of the retina (as shown by electrophysiological studies) while that in the subretinal neovascular membrane diminished retinal edema, improved the patients' general condition, far vision, and increased comfort on reading.
Sarygina
O I
OI
Zaĭtseva
O V
OV
D000065:Accommodation, Ocular; D000328:Adult; D001248:Asthenopia / Q000188:drug therapy*; D002338:Carotenoids / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D017060:Patient Satisfaction; D011932:Reading; D013997:Time Factors; D014131:Trace Elements / Q000008:administration & dosage*; D016896:Treatment Outcome; D014792:Visual Acuity; D014815:Vitamins / Q000008:administration & dosage*
D014131:Trace Elements; D014815:Vitamins; D002338:Carotenoids